Environmental health scientists at the University of Cincinnati (UC) say they have confirmed what other scientists have only suspected: early-life exposure to certain indoor fungal components (molecules) can help build stronger immune systems, and may protect against future allergies.
Breast cancer is the most prevalent type of invasive cancer attacking women in the United States. Last year alone some 213,000 women were diagnosed with the disease. The good news is that two million women have survived. Many women with breast cancer seek complementary interventions that will enhance their quality of life. Yet research is lacking whether these programs such as yoga, also benefit immune function.
A new study from the University of Michigan Health System suggests that a compound in green tea may provide therapeutic benefits to people with rheumatoid arthritis.
In earlier work, Northwestern University scientist Mary J.C. Hendrix and colleagues discovered that aggressive melanoma cells (but not normal skin cells nor less aggressive melanoma cells) contain specific proteins similar to those found in embryonic stem cells.
National Osteoporosis Month is right around the corner, reminding most health professionals to counsel their clients about the bone-building benefits of calcium and vitamin D.
Scientists at The University of Nottingham have been awarded over ?366,000 to help unravel the mystery of a stomach bug which causes gastric ulcers and cancer. Their research could lead to the development of a vaccine for those most at risk.
A Rochester physician is helping to coordinate the national response against lupus. I?aki Sanz, M.D., professor of Medicine, Microbiology and Immunology, has been named chair of the research committee of the Lupus Foundation of America.
Researchers have shown that a drug that was extensively tested against cancer may also qualify as a new drug against African sleeping sickness.
An effective way to fight leukemia might be to knock out a specific protein that protects cancer cells from dying, a new study shows. The findings suggest that a drug that can block this “survival protein” might on its own be an effective therapy.
Autoimmune diseases such as type I diabetes and rheumatoid arthritis are caused by the immune system attacking the body?s own tissues.